Experiments were designed to measure glutathione-reductase (GR) activity in mouse skin treated with 4-tertiary-butyl-catechol (98293) (TBC). Three groups of five Uscd-mice were treated as follows: group 1, left ear with TBC dissolved in dimethyl-sulfoxide (DMSO) and acetone and right ear with DMSO/acetone; group 2, left ear with TBC and right ear no treatment; group 3, left ear with DMSO and right ear no treatment. The TBC solution or the solvent was applied topically three times at 48 hour intervals. TBC treated skin demonstrated significant increases in GR activity. The enzyme levels in the nontreated and solvent treated ears failed to show significant changes. Neither skin color changes nor melanocyte degeneration were observed following TBC treatment. Electron microscopy showed that TBC treatment resulted in pheomelanin formation. The elevation in GR was detectable even before pheomelanin production. This caused the authors to suggest the possibility that occupational leukoderma may be detectable before the clinical change develops and this may help in the health management of this condition.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.